449 purchase as supplier for a total of 512,272.3 between 2009 and 2014.
Overcost in MXN
289,816.7 pesos mexicanos
Overcost in %
1,459.8 %
| Product | Purchases | Total amount | Overcost in MXN | Overcost in % | Period |
|---|---|---|---|---|---|
| GABAPENTINA | 15 | 20,466 MXN | 18,195.2 MXN | 813.1 % | 2009 - 2010 |
| ATORVASTATINA | 15 | 32,996 MXN | 28,286.6 MXN | 1,437.4 % | 2009 - 2012 |
| SALMETEROL FLUTICASONA | 11 | 11,429 MXN | 5,424.3 MXN | 88.3 % | 2009 - 2009 |
| PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL | 11 | 7,427 MXN | 7,230.1 MXN | 3,666.7 % | 2009 - 2010 |
| PROPRANOLOL | 10 | 1,441 MXN | 1,110.9 MXN | 492.8 % | 2009 - 2012 |
| PRAVASTATINA | 9 | 8,217 MXN | 8,058 MXN | 5,078.6 % | 2009 - 2009 |
| LOSARTÁN | 9 | 15,411 MXN | 15,040.6 MXN | 4,029.6 % | 2009 - 2009 |
| TELMISARTÁN | 8 | 18,797 MXN | 14,884.1 MXN | 393.4 % | 2009 - 2012 |
| PENTOXIFILINA | 6 | 2,890 MXN | 2,759.7 MXN | 2,197.4 % | 2009 - 2009 |
3 contract as supplier for a total of 745,000 between 2003 and 2007.
Country
Identifiers
RFC: GOSM530106858
Date updated in QQW
9 de mayo de 2021
Source(s)
Part of the project
Organization responsible for the import